SCHEMBL7414878

SCHEMBL7414878

CC(=O)Nc1ccc(C(=O)NCC(C(=O)N(Cc2ccccc2)C2(C#N)CCNCC2)C2CCCCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.41
CTSS P25774 1/20 0.40
LMNA P02545 1/20 0.38
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
HTT P42858 1/20 0.35
NAMPT P43490 2/20 0.35
HDAC1 Q13547 1/20 0.35
MCHR1 Q99705 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
DHODH Q02127 1/20 0.35
NPC1 O15118 1/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TMEM97 Q5BJF2 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7014342 0.85 CTSS (0.41) CTSSMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL7419141 0.84 AGER (0.39) LMNAHTTTMEM97SIGMAR1PRMT5
SCHEMBL7414874 0.84 CTSS (0.46) BACE1CTSS
SCHEMBL7417235 0.79 L3MBTL1 (0.35) LMNAHTTMEN1KMT2AALDH1A1
SCHEMBL7422438 0.79 PKM (0.42) CTSSLMNAMCHR1MEN1KMT2A
SCHEMBL7413191 0.75 CTSS (0.37) CTSSLMNAHTTALDH1A1RAB9A
SCHEMBL7420833 0.75 L3MBTL1 (0.41) CTSSHTTMEN1KMT2AALDH1A1
SCHEMBL7413188 0.74 CTSS (0.39) CTSSLMNAHTTALDH1A1SMN1; SMN2
SCHEMBL7414894 0.71 CTSS (0.45) BACE1CTSS
SCHEMBL7415423 0.70 CTSS (0.43) BACE1CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed